Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Nov 22, 2025

Three-Dimensional Shape Modeling and Analysis of Brain Structures
05:33

Three-Dimensional Shape Modeling and Analysis of Brain Structures

Published on: November 14, 2019

7.4K

SRD5A3-CDG: 3D structure modeling, clinical spectrum, and computer-based dysmorphic facial recognition.

Ikhlas Ben Ayed1,2,3, Wael Ouarda4, Fakher Frikha5

  • 1Laboratory of Molecular and Cellular Screening Processes (LPCMC), LR15CBS07, Center of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia.

American Journal of Medical Genetics. Part A
|January 6, 2021
PubMed

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbial dysbiosis and inferred functional profiling reveals the potential role of <i>Methylobacterium</i> in prostate cancer.

Frontiers in cellular and infection microbiology·2026
Same author

Hybrid Whole-Genome Sequencing of <i>Penicillium crustosum</i> CTM10622 Uncovers a Highly Thermostable Alkaline Serine Lipase with Biotechnological Relevance.

International journal of molecular sciences·2026
Same author

Assessment of CD26+ Leukemic Stem Cells in Tunisian Patients with Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitor Therapy.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2026
Same author

Drug repositioning as an antivirulence strategy: Ketoprofen targets quorum sensing and biofilm in Serratia sp.

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]·2026
Same author

Comprehensive <i>BRCA1/2</i> mutation landscape in prostate cancer in the UAE and Arab population.

Frontiers in cell and developmental biology·2026
Same author

Characterization of mosquitocidal Bacillus thuringiensis strains and identification of a Cry30G variant.

International journal of biological macromolecules·2026
Summary

This study identifies a new pathogenic variant in SRD5A3, aiding in the diagnosis of SRD5A3-congenital disorder of glycosylation (CDG). A novel computer tool was developed for accurate facial recognition of SRD5A3-CDG patients.

Area of Science:

  • Genetics and Molecular Biology
  • Biochemistry
  • Medical Genetics

Background:

  • Steroid 5 alpha reductase type 3 (SRD5A3) pathogenic variants cause SRD5A3-congenital disorder of glycosylation (CDG), a rare inherited condition.
  • While dysmorphic features are common in SRD5A3-CDG, a distinct facial recognition entity has not been established.
  • Previous reports detail 43 affected individuals, highlighting the need for improved diagnostic tools.

Purpose of the Study:

  • To report a novel SRD5A3 pathogenic variant and analyze its structural impact.
  • To identify common clinical and dysmorphic features associated with SRD5A3-CDG.
  • To develop and validate a computer-based tool for accurate facial recognition and diagnosis of SRD5A3-CDG.

Main Methods:

  • Identification and characterization of a novel SRD5A3 missense variant (c.460T>C, p.(Ser154Pro)).
Keywords:
3D structure modelingcongenital disorders of glycosylationexome-clinical sequencingfacial recognitionpolyprenol reductase

More Related Videos

Author Spotlight: Three-Dimensional Cephalometric Landmark Annotation Demonstration on Human Cone Beam Computed Tomography Scans
10:23

Author Spotlight: Three-Dimensional Cephalometric Landmark Annotation Demonstration on Human Cone Beam Computed Tomography Scans

Published on: September 8, 2023

3.3K
Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
09:30

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps

Published on: July 19, 2024

1.7K

Related Experiment Videos

Last Updated: Nov 22, 2025

Three-Dimensional Shape Modeling and Analysis of Brain Structures
05:33

Three-Dimensional Shape Modeling and Analysis of Brain Structures

Published on: November 14, 2019

7.4K
Author Spotlight: Three-Dimensional Cephalometric Landmark Annotation Demonstration on Human Cone Beam Computed Tomography Scans
10:23

Author Spotlight: Three-Dimensional Cephalometric Landmark Annotation Demonstration on Human Cone Beam Computed Tomography Scans

Published on: September 8, 2023

3.3K
Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
09:30

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps

Published on: July 19, 2024

1.7K
  • 3D structural modeling of the SRD5A3 protein to predict the variant's effect on catalytic efficiency.
  • Phenotypic analysis of patient data and published cases, including facial 2D image analysis.
  • Development and validation of a computer-based dysmorphic facial analysis tool.
  • Main Results:

    • A novel pathogenic missense variant, c.460T>C p.(Ser154Pro), in SRD5A3 was identified and structurally modeled.
    • The p.(Ser154Pro) variant is predicted to be in a potential active site, potentially reducing catalytic efficiency.
    • Common dysmorphic features include arched eyebrows, wide eyes, a shallow nasal bridge, short nose, and a large mouth.
    • A computer-based facial analysis tool achieved 92.5% accuracy in recognizing SRD5A3-CDG.

    Conclusions:

    • The study integrates genotypic, structural, and phenotypic data for SRD5A3-CDG.
    • A novel pathogenic SRD5A3 variant was characterized, providing insights into disease mechanisms.
    • The developed computer tool significantly aids in the global diagnosis of SRD5A3-CDG by enabling accurate facial recognition.